# SpO2 Verification Study - Philips Nasal Alar With Nellcor OxiMax SpO2 Board (453564624031)

> **NCT07680530** · — · COMPLETED · sponsor: **Philips Clinical & Medical Affairs Global** · enrollment: 43 (actual)

## Conditions studied

- Pulse Oximetry

## Interventions

- **OTHER:** Evaluation of Oxygen Sensors

## Key facts

- **NCT ID:** NCT07680530
- **Lead sponsor:** Philips Clinical & Medical Affairs Global
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2026-05-28
- **Primary completion:** 2026-06-29
- **Final completion:** 2026-06-29
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2026-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07680530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07680530, "SpO2 Verification Study - Philips Nasal Alar With Nellcor OxiMax SpO2 Board (453564624031)". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07680530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*